Medyssey
South Korean spinal implant manufacturer specializing in orthopedic and neurosurgical implants, including 3D-printed patient-specific titanium implants.
- CEO / Founder
- Seong Gyung-soo (성경수)
- Team Size
- 51-200
- Stage
- Public
- Total Funding
- $13.7M
- Latest Round
- Acquired
- Key Investors
- Dongwha Pharm (동화약품); NongHyup Bank; IBK Capital Corporation
Technology & Products
Key Products
Thoracolumbar Spinal Systems (Zenius, KORA, ILIAD); Interbody Cages (EP Cage, LP Cage, BN Cage, C7 Cage, Medussa 3D-printed cages, Triton hybrid cages); Cervical Systems; Custom-FIT patient-specific 3D-printed implants (MCS cranial, MCB complex anatomical); MIS (Minimally Invasive Surgery) Systems; Posterior OCT System; Athena II Plate System; WaveFleX Posterior Semi-rigid System; VariAn Expandable Cage; Dynamic PLIF Cage; Interspinous OMEGA
Technological Advantage
Pioneer in metal 3D printing for spinal implants (introduced first metal 3D printer in Korea in 2011); owns ARCAM EBM machines for titanium implant production; FDA 510(k) clearances for multiple 3D-printed cage systems (Medussa, Medussa II, Triton); 26 registered patents, 16 patent applications; ISO 13485, CE Mark, KFDA, Health Canada, ANVISA certifications.
Differentiation
Value Proposition
Designs, develops, manufactures and markets spinal implants for the surgical treatment of spine disorders, with a focus on motion preservation, dynamic stabilization, and 3D-printed patient-specific implants.
How They Differentiate
Only Korean spinal implant maker with in-house metal 3D printing (EBM) for patient-specific implants; comprehensive full-spine product portfolio; strong export orientation with 50%+ revenue from overseas; competitive pricing vs. global giants; subsidiary of major pharmaceutical group (Dongwha Pharm) providing financial stability.
Market & Competition
Target Customers
Orthopedic and neurosurgical spine surgeons, hospitals, and medical distributors globally.
Industry Verticals
Medical Devices; Orthopedic Surgery; Neurosurgery; Spinal Surgery
Competitors
Stryker (3D-printed spine implants); Johnson & Johnson/DePuy Synthes; Zimmer Biomet; Globus Medical; NuVasive
Growth & Milestones
Growth Metrics
2025 revenue: ₩27.7B (~$21M); 2024 overseas revenue: $10.63M (up 10% YoY); 2024 total revenue: ₩25.5B with operating profit ₩3.2B; 5 consecutive years of operating profit; 3D-printed spinal implant sales up 29% in 2024 to ₩760M.
Major Milestones
2003: Founded as Varian Co., Ltd.; 2007: Renamed to Medyssey Co., Ltd.; 2011: Introduced Korea's first metal 3D printer (ARCAM EBM); 2012: First FDA 510(k) clearance for spinal system; 2015: Listed on KONEX (ticker: 200580); 2017: First FDA clearance for 3D-printed porous interbody fusion device; 2020: Acquired by Dongwha Pharm for ~₩20B; 2024: Appointed Seong Gyung-soo as sole CEO; 2025: Global sales surpassed $10M; 2026: Preparing KOSDAQ transfer with Daishin Securities as underwriter.
Notable Customers
Distributes to hospitals and spine surgeons across 30+ countries including USA, Thailand, Chile, Mexico, Brazil, India, and throughout Asia Pacific, EU, and Middle East.